PAA 2.86% 18.0¢ pharmaust limited

PAA Chart, page-72

  1. 1,633 Posts.
    lightbulb Created with Sketch. 579
    lol, I thought he was referring to NZT Trader……. Anyway if Monepantel continues to shine, someone mentioned “our own subsidiary” you know the really respected and trusted side….”Ephicem”, scale up, produce Monepantel, Distribute to MND Foundations, that if not already have, could get a “resident doctor” to subscribe all patients? Not sure how these things work but 300,000 sufferers worldwide is big, but not unmanageable, they would have information hubs/foundations worldwide YES/NO? Without Big Pharma even??
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.